Kemper Q2 Results: Adjusted EPS beats estimate, sales miss
Kemper's Q2 adjusted EPS of $0.45 beat the $0.34 estimate, though it fell 65.38% YoY from $1.30. Sales of $1.092 billion missed the $1.121B estimate and dropped 10.93% from $1.226 billion in the prior year period.

*this image is generated using AI for illustrative purposes only.
Kemper (NYSE: KMPR) reported second-quarter adjusted earnings per share of $0.45, beating the analyst consensus estimate of $0.34 by 32.35 percent, while quarterly sales of $1.092 billion missed the $1.121 billion estimate by 2.55 percent. The divergence between earnings performance and revenue results highlights a mixed financial picture for the insurer in the quarter.
Despite the earnings beat, the company’s profitability metrics show a significant year-over-year contraction. The reported EPS represents a 65.38 percent decrease from the $1.30 per share recorded in the same period last year. This sharp decline underscores the pressure on margins even as the company outperformed immediate market expectations for the current quarter.
Revenue figures also reflected a downward trend compared to the previous year. Sales of $1.092 billion were down 10.93 percent from the $1.226 billion reported in the corresponding period of the prior fiscal year. The miss against the analyst consensus of $1.121 billion suggests softer-than-anticipated top-line growth.
Financial Performance Overview
The following table summarizes the key financial metrics for Kemper’s second quarter:
| Metric | Actual | Estimate | YoY Change |
|---|---|---|---|
| Adjusted EPS | $0.45 | $0.34 | -65.38% |
| Sales | $1.092 billion | $1.121 billion | -10.93% |
What the Numbers Show
The primary driver of the earnings beat was likely operational efficiency or favorable non-operational items, given that revenue declined significantly. While the company managed to deliver an EPS that exceeded analyst expectations by over 30 percent, the underlying revenue base shrank by nearly 11 percent year-over-year. This pattern indicates that the earnings improvement was not driven by top-line growth but rather by cost management or other factors offsetting the revenue decline.
What specific cost-cutting measures or operational efficiencies enabled Kemper to beat EPS estimates despite an 11% revenue decline?
How might the significant year-over-year contraction in profitability impact Kemper's dividend sustainability and shareholder return policies?
Which specific insurance segments contributed most to the top-line miss, and does this signal broader weakness in the property and casualty market?



























